Voya Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Voya Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,628	Closed	-$250K	–	553
2017 Q2	$250K	Buy	7,628 +885	+13%	+$27.4K	0.02%	421
2017 Q1	$223K	Sell	6,743 -342	-5%	-$11.7K	0.02%	439
2016 Q4	$256K	Buy	7,085 +547	+8%	+$21.8K	0.02%	392
2016 Q3	$303K	Buy	6,538 +1,505	+30%	+$78.5K	0.03%	328
2016 Q2	$253K	Buy	+5,033	New	+$268K	0.03%	338
2016 Q1	–	Sell	-3,438	Closed	-$227K	–	407
2015 Q4	$227K	Buy	+3,438	New	+$212K	0.03%	316

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Voya Financial Advisors's TEVA Position: Q3 2017 in Review

Voya Financial Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 7,628 shares — an estimated $250K sold.

Voya Financial Advisors first reported a position in TEVA in Q4 2015 and held it in 6 quarters. The position peaked at $303K in Q3 2016. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Voya Financial Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
Voya Financial Advisors sold 7,628 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $250K.
Voya Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 6 quarters.
Voya Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $303K in Q3 2016.
537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Voya Financial Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.